P. Lando

发表

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen

M. Dohlsten, L. Ohlsson, G. Forsberg, 2001, British Journal of Cancer.

Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma

L. Abrahmsén, L. Ohlsson, T. Brodin, 2000, Cancer Immunology, Immunotherapy.

Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma

U. Andersson, T. Kalland, J. Andersson, 1996, European journal of immunology.

Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter.

E. Parra, E. Michaëlsson, M. Dohlsten, 1998, International immunology.

Immunotherapy of human colon cancer by antibody-targeted superantigens

L. Abrahmsén, T. Kalland, M. Dohlsten, 1995, Cancer Immunology, Immunotherapy.

An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.

T. Edgington, P. Lando, 1985, Journal of immunology.

Determination of the Immunoglobulin Class of Complement‐dependent Cytotoxic Antibodies in Serum of D23 Hepatoma‐bearing Rats

P. Perlmann, P. Lando, K. Berzins, 1980, Scandinavian journal of immunology.

Complement‐Dependent Cytotoxicity Against Hepatoma Cells Mediated by IgM Antibodies in Serum from Tumor‐Bearing Rats‐

P. Perlmann, P. Lando, K. Berzins, 1977, Scandinavian journal of immunology.

Human major histocompatibility complex class II‐negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor

T. Kalland, G. Hedlund, A. Kelly, 1991, European journal of immunology.

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens

T. Kalland, G. Hedlund, M. Dohlsten, 2005, Cancer Immunology, Immunotherapy.

Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A

T. Kalland, G. Hedlund, M. Dohlsten, 2005, Cancer Immunology, Immunotherapy.

Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR+ mononuclear leukocytes and freshly prepared leukemia cells.

T. Kalland, G. Hedlund, M. Dohlsten, 1990, Cellular immunology.

A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.

H. Macdonald, H. Sjögren, T. Kalland, 1991, Journal of immunology.

Targeting of superantigens

L. Abrahmsén, T. Kalland, G. Hedlund, 2009, Cell Biophysics.

Monoclonal antibodies and superantigens: A novel therapeutic approach

T. Kalland, G. Hedlund, A. Sundstedt, 1993, Medical oncology and tumor pharmacotherapy.

Role of the adhesion molecule ICAM‐1 (CD54) in staphylococcal enterotoxin‐mediated cytotoxicity

J. Trowsdale, D. Altmann, M. Patarroyo, 1991, European journal of immunology.

An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.

P. Lando, R. A. Cooper, M. Greenberg, 1972, The Journal of clinical investigation.

Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.

T. Kalland, G. Hedlund, M. Dohlsten, 1993, Immunology.

Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.

M. Kotb, T. Kalland, M. Dohlsten, 1996, Journal of immunology.

Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linker.

T. Kalland, G. Hedlund, M. Dohlsten, 1993, Bioconjugate chemistry.

Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

L. Abrahmsén, G. Hedlund, C. Förberg, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity.

T. Kalland, G. Hedlund, M. Dohlsten, 1991, Current topics in microbiology and immunology.

Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.

P. Perlmann, P. Lando, K. Berzins, 1981, British Journal of Cancer.

Tumor-associated cytotoxicity of autoantibodies in sera from rats with chemically induced hepatomas.

P. Perlmann, P. Lando, K. Berzins, 1980, Cancer research.

Arylamidases of rat liver and chemically induced hepatomas. 1. Subcellular distribution of L-leucine. 2. Naphthylamidase-active antigens.

P. Lando, K. Berzins, F. Blomberg, 1977, Biochimica et biophysica acta.

Arylamidases of rat liver and chemically induced hepatomas. II. Preparation and characterization of monospecific antisera against two distinct arylamidase-active antigens.

P. Lando, K. Berzins, F. Blomberg, 1977, Biochimica et biophysica acta.

A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.

T. Kalland, M. Dohlsten, P. Lando, 1997, Blood.

Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

T. Kalland, G. Hedlund, M. Dohlsten, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

J. Trowsdale, T. Kalland, G. Hedlund, 1990, Immunology.

Antibody-targeted superantigens in cancer immunotherapy.

J. Hansson, P. Antonsson, T. Kalland, 1996, Immunotechnology : an international journal of immunological engineering.

Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.

K. Lundin, M. Kotb, T. Kalland, 1996, Journal of immunology.

Amidolytic assay for procoagulant activity of lymphoid and tumor cells.

T. Edgington, P. Lando, C. E. Biazak, 1986, Journal of immunological methods.

Tumor‐reactive superantigens suppress tumor growth in humanized scid mice

T. Kalland, M. Dohlsten, L. Ohlsson, 1995, International journal of cancer.

The TcR‐CD3 Complex is Required for Activation of Human Lymphocytes with Staphylococcal Enterotoxin A

T. Kalland, M. Dohlsten, P. Lando, 1990, Scandinavian journal of immunology.

Lymphoid procoagulant response to bacterial endotoxin in the rat

T. Edgington, P. Lando, 1985, Infection and immunity.

A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma.

R. Vessella, T. Kalland, G. Hedlund, 1995, International immunology.

Genetically engineered superantigens in experimental tumor therapy

J. Hansson, P. Antonsson, T. Kalland, 2005, Springer Seminars in Immunopathology.